Skip to content

Nerve Growth Factor in Chronic Pancreatitis

Nerve Growth Factor in Chronic Pancreatitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01255917
Enrollment
38
Registered
2010-12-08
Start date
2008-02-29
Completion date
2011-08-31
Last updated
2016-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis

Keywords

Tio identify role of NGF in pain in CP, Identify biomarkers related to progression of CP

Brief summary

This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis. Hypothesis: 1. Pain does not correlate with changes in the PD morphology suggesting that pain in CP is not only a mechanical problem 2. Pain in CP correlates better with the levels of NGF in the pancreatic juice. NGF is variably expressed in different morphological stages of CP and regulates the sensitivity of the peptidergic nociceptors and is upregulated in pancreatic inflammation.

Interventions

None listed

Sponsors

Stanford University
CollaboratorOTHER
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with established CP and none of the

Exclusion criteria

mention below.

Design outcomes

Primary

MeasureTime frame
The levels of NGF in subjects with different morphological stages of chronic pancreatitis (CP) will be compared to the controls and in each morphological stage of CP will be correlated with pain scores.5 years

Secondary

MeasureTime frame
Correlate the expression of NGF and other inflammatory cytokines in the pancreatic juice in each morphological stage of CP.5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026